[5-year results of a chemo-immunotherapeutic treatment in stage-I and -II malignant melanoma].
Comella
G
G
Mastro
A A
AA
Comella
P
P
Castello
G
G
De Simone
G
G
Cerra
R
R
Zarrilli
D
D
D000206:Actuarial Analysis; D000328:Adult; D000368:Aged; D001500:BCG Vaccine / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008197:Lymph Node Excision; D008545:Melanoma / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D008875:Middle Aged; D009367:Neoplasm Staging; D011182:Postoperative Care; D001749:Urinary Bladder Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy
D001500:BCG Vaccine; D003606:Dacarbazine
Risultati a 5 anni di un trattamento chemioimmunoterapico del melanoma maligno al I e II stadio.